This website uses cookies to improve user experience. By continuing to use this website, you consent to our use of these cookies. To learn more about how we use and manage cookies, see our Privacy Policy and Cookie Policy.
You or your patient can call
BERINERT Connect at
1-877-236-4HAE
(1-877-236-4423), Monday–Friday,
8 AM–8 PM ET.
1-877-236-4HAE
(1-877-236-4423), Monday–Friday,
8 AM–8 PM ET.
Provides ongoing, one-on-one support throughout the BERINERT journey
Conducts benefits verification and provides information about the prior authorization process (if applicable) and financial support through a variety of patient-assistance programs, if needed
Personalized support from a dedicated case manager
Self-administration education and support for patients, parents, and/or caregivers
Financial assistance programs to include co-pay support and insurance navigation for eligible patients*
*Terms and conditions apply.
REIMBURSEMENT & CODING
CSL Behring is dedicated to making BERINERT available to patients and healthcare professionals when and where it is needed. BERINERT is available through a range of national and regional specialty pharmacies and distributors.
For contact information for these organizations, please call BERINERT Connect at 1-877-236-4HAE
(1-877-236-4423).(1-877-236-4423).
HCPCS Code1(Healthcare Common Procedural Coding System)
J0597
Injection, C1 Esterase Inhibitor (Human), BERINERT, 10 units
ICD-10-CM Diagnosis Code2(Identifies the medical condition of the patient)
D84.1
Defects in the complement system
C1 esterase inhibitor (C1-INH) deficiency
CPT® Administration Codes: Physician Office3-4
96374
Intravenous push, single, or initial substance/drug
96376
Each additional sequential intravenous push of the same substance /drugsubstance/drug provided in a facility (list separately in addition to code for primary procedure)
BERINERT National Drug Codes (NDCs)
Product kit
NDC number from package insert
NDC number to use on claim forms
Carton contains:
One single-dose vial of BERINERT
One 10 mL vial of diluent (Sterile Water for Injection, USP)
One Mix2Vial® filter transfer set
10 mL silicone-free syringe
IV set and butterfly needle
Alcohol swab
BERINERT package insert
63833-825-02
63833-0825-02
Disclaimer: The codes being provided are a complex and evolving medical coding system. The treating physician is solely responsible for diagnosis coding and determination of the appropriate ICD-10-CM codes that describe the patient’s conditions and are supported by the medical record. All codes listed in this guide are for informational purposes and are not an exhaustive list. The CPT®, HCPCS, and ICD-10-CM codes are provided based on AMA or CMS guidelines. The billing party is solely responsible for coding of services (eg, CPT coding). Because government and other third-party payer coding requirements change periodically, please verify current coding requirements directly with the payer being billed.
IDENTIFYING HAE
HAE is often misdiagnosed because the symptoms mimic those of several common conditions, including allergic angioedema and GI problems. But HAE is not an allergy. It is a rare, inherited disease that, in most cases, is caused by C1 esterase inhibitor (C1-INH) deficiency, and can be fatal if not properly treated.
Undiagnosed HAE can take a toll on patients
It’s important to determine the difference between allergic angioedema, GI problems, and HAE because the pathophysiology and the treatment of the diseases are different. HAE patients are often subjected to nonessential medical procedures, such as unnecessary surgeries, or ineffective treatments, such as antihistamines. HAE should be suspected when a patient presents with a history of recurrent angioedema, especially if hives are absent.5
Differentiate with 8
Consider 8 questions to identify a potential HAE patient6
8 questions can help differentiate HAE from other angioedema. Download the PDF or use the interactive tool below.
Sponsored by CSL Behring, All About HAE is an online resource for the community of HAE patients, families, and healthcare professionals seeking more information about HAE symptoms and living with HAE.
CSL Behring is a proud supporter of the US Hereditary Angioedema Association (HAEA) a nonprofit patient advocacy organization dedicated to expediting US approval of safer and more effective HAE therapies. The organization provides a wide range of services that include clinical trial placement, physician referrals, education, and individualized patient case management.
References: 1. Centers for Medicare and Medicaid Services. HCPCS quarterly update. HCPCS July 2021 index. https://www.cms.gov/Medicare/Coding/HCPCSReleaseCodeSets/ HCPCS-Quarterly-Update. Accessed June 17, 2021.
2. National Center for Health Statistics (US Department of Health and Human Services) International Classification of Diseases, Tenth Revision, Clinical Modification (ICD-10-CM). 2021 Codes Tables and Index. https://www.cdc.gov/nchs/icd/icd10cm.htm. Accessed June 17, 2021.
3. 2021 CPT Code 96374. American Academy of Professional Coders website. https://www.aapc.com/codes/cpt-codes/96369. Accessed June 17, 2021.
4. 2021 CPT Code 96376. American Academy of Professional Coders website. https://www.aapc.com/codes/cpt-codes/96370. Accessed June 17, 2021.
5. Nzeako UC, Frigas E, Tremaine WJ. Hereditary angioedema: a broad review for clinicians. Arch Intern Med. 2001;161(20):2417-2429.6. Bork K, Meng G, Staubach P, Hardt J. Hereditary angioedema: new findings concerning symptoms, affected organs and course. Am J Med. 2006;119(3):267-274.
7. Prematta MJ, Kemp JG, Gibbs JG, Mende C, Rhoads C, Craig TJ. Frequency, timing, and type of prodromal symptoms associated with hereditary angioedema attacks. Allergy Asthma Proc. 2009;30(5):506-511.
8. Zuraw BL. Clinical practice: hereditary angioedema. N Engl J Med. 2008;359(10):1027-1036.
×
Your patients can save with the BERINERT Co-Pay Program
While living with HAE carries a heavy burden, there is help. The BERINERT Co-Pay Program* is a financial assistance program designed to help patients pay for eligible out-of-pocket expenses.
*
Subject to terms and conditions of the copay assistance program. To read the full terms and conditions, visit cslbehring.com/patients/support-and-assistance. CSL Behring reserves the right to rescind, revoke, or amend the program at any time without notice.
